Johnson & Johnson (NYSE:JNJ) CEO Alex Gorsky said people may need COVID-19 vaccines annually, like flu shots, over the next several years.
Speaking to CNBC, Gorsky cited the mutations and variants of the disease, several of which have already landed in the U.S., as the driving force behind differentiating capabilities of the vaccine to fight off antibodies. Previous suggestions have indicated that COVID-19 could become a flu-like endemic disease, too.
Get the full story at our sister site, Pharmaceutical Processing World.